Skip to main content
Premium Trial:

Request an Annual Quote

So Much for That: Mar 1, 2012

The Research Works Act has been officially dropped, reports ScienceInsider's Jocelyn Kaiser. The proposed bill, which would have banned NIH from requiring that its researchers allow the public to access their work, engendered much outrage from the research community, and caused thousands of researchers to start a boycott of publisher Elsevier for its support of the Act, Kaiser says. A recent report suggested that the bill wouldn't move forward in Congress this year, shortly before Elsevier announced it was dropping its support of the bill. RWA's sponsors, representatives Darrell Issa (R-CA) and Carolyn Maloney (D-NY), released a statement saying the act had outlived its usefulness, Kaiser adds.

Our sister publication GenomeWeb Daily News has more on this story.

The Scan

Could Cost Billions

NBC News reports that the new Alzheimer's disease drug from Biogen could cost Medicare in the US billions of dollars.

Not Quite Sent

The Biden Administration likely won't meet its goal of sending 80 million SARS-CoV-2 vaccine doses abroad by the end of the month, according to the Washington Post.

DTC Regulation Proposals

A new report calls on UK policymakers to review direct-to-consumer genetic testing regulations, the Independent reports.

PNAS Papers on Mosquito MicroRNAs, Acute Kidney Injury, Trichothiodystrophy

In PNAS this week: microRNAs involved in Aedes aegypti reproduction, proximal tubule cell response to kidney injury, and more.